Literature DB >> 31342592

Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes.

Leanne de Kock1,2, Mona K Wu1,2, William D Foulkes1,2,3.   

Abstract

DICER1 syndrome is a pleiotropic tumor predisposition syndrome characterized by a distinctive constellation of neoplastic and dysplastic lesions, which are generally rare and affect children and young adults. Germline pathogenic variants in the DICER1 gene are the underlying cause of the syndrome; variants are typically inherited in an autosomal dominant pattern but may arise de novo in the germline or in a somatic mosaic distribution. The encoded DICER1 protein is a key component of the microRNA processing pathway. In this Mutation Update, we present a comprehensive review of all DICER1 genetic alterations reported in articles published before January 31st, 2019. A total of 1,136 DICER1 alterations were catalogued from 808 individuals and the tumors that occurred in these persons. We provide an inventory of these DICER1 alterations and discuss them with respect to their provenance, distribution across the gene, associated phenotypes and ages of onset, and penetrance. We also address approaches to classification of DICER1 variants of uncertain significance and discuss the clinical significance of DICER1 variant identification.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  DICER1; DICER1 syndrome; mutation spectrum; mutations; variants

Mesh:

Substances:

Year:  2019        PMID: 31342592     DOI: 10.1002/humu.23877

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  26 in total

1.  Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8.

Authors:  Leanne de Kock; Barbara Rivera; William D Foulkes
Journal:  Acta Neuropathol       Date:  2020-03-02       Impact factor: 17.088

Review 2.  Hematologic indices in individuals with pathogenic germline DICER1 variants.

Authors:  Lauren M Vasta; Nicholas E Khan; Cecilia P Higgs; Laura A Harney; Ann G Carr; Anne K Harris; Kris Ann P Schultz; Mary L McMaster; Douglas R Stewart
Journal:  Blood Adv       Date:  2021-01-12

Review 3.  Tumour predisposition and cancer syndromes as models to study gene-environment interactions.

Authors:  Michele Carbone; Sarah T Arron; Bruce Beutler; Angela Bononi; Webster Cavenee; James E Cleaver; Carlo M Croce; Alan D'Andrea; William D Foulkes; Giovanni Gaudino; Joanna L Groden; Elizabeth P Henske; Ian D Hickson; Paul M Hwang; Richard D Kolodner; Tak W Mak; David Malkin; Raymond J Monnat; Flavia Novelli; Harvey I Pass; John H Petrini; Laura S Schmidt; Haining Yang
Journal:  Nat Rev Cancer       Date:  2020-05-29       Impact factor: 60.716

Review 4.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

5.  Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.

Authors:  Leanne de Kock; Ju-Yoon Yoon; Blaise A Clarke; William D Foulkes; Maria Apellaniz-Ruiz; Dylan Pelletier; W Glenn McCluggage; Colin J R Stewart; Brendan C Dickson; Marjan Rouzbahman
Journal:  Mod Pathol       Date:  2020-01-03       Impact factor: 7.842

6.  Clinical Outcomes and Complications of Pituitary Blastoma.

Authors:  Anthony P Y Liu; Megan M Kelsey; Nelly Sabbaghian; Sung-Hye Park; Cheri L Deal; Adam J Esbenshade; Oswald Ploner; Andrew Peet; Heidi Traunecker; Yomna H E Ahmed; Margaret Zacharin; Anatoly Tiulpakov; Anastasia M Lapshina; Andrew W Walter; Pinaki Dutta; Ashutosh Rai; Márta Korbonits; Leanne de Kock; Kim E Nichols; William D Foulkes; John R Priest
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

7.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

8.  Molecular characterization of DICER1-mutated pituitary blastoma.

Authors:  Javad Nadaf; Leanne de Kock; Anne-Sophie Chong; Márta Korbonits; Paul Thorner; Naciba Benlimame; Lili Fu; Andrew Peet; Justin Warner; Oswald Ploner; Shanop Shuangshoti; Steffen Albrecht; Nancy Hamel; John R Priest; Barbara Rivera; Jiannis Ragoussis; William D Foulkes
Journal:  Acta Neuropathol       Date:  2021-03-01       Impact factor: 17.088

Review 9.  Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli-Leydig Cell Tumor.

Authors:  Elisa De Paolis; Rosa Maria Paragliola; Paola Concolino
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

Review 10.  Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature.

Authors:  L Samuel Hellgren; Martin Hysek; Kenbugul Jatta; Jan Zedenius; C Christofer Juhlin
Journal:  Head Neck Pathol       Date:  2020-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.